Date :
Place : United States, Philadelphia
Contact Person:Paula Edwards
Description:
As clinical trials are conducted, inspections ensure quality and integrity of care, data and drug performance. As sponsors for clinical trials, pharmaceutical companies are required to ensure GCP guidelines are upheld by implementing inspection readiness. These inspections are conducted by regulatory authorities, which all have unique regulations and caveats. These nuances make inspection readiness a difficult and resource-consuming battle. Clinical trials must be prepared for visits from countless stakeholders over their course.Deadline for abstracts/proposals : 1st August 2017
Organized By :New York Events List
Keynote Speakers :
Conference Highlights :Use different perspectives on inspection readiness to improve clinical operations and guarantee success Promote and ensure compliance with all regulatory agencies and their regulations using new systems and innovative methodologies Ensure trials are organized with improved oversight and communication to protect study participants’ rights, safety and welfare Foster the intelligent design of clinical trial inspection readiness procedures by identifying trends that improve and encourage
Venue :Philadelphia, PA 19103, United States
Check the event website for more details.